Sure is a lot of fuss about a company missing EPS by 1% for 1 half. Some would call that variation almost random.
Defensive earnings stream, still growing at 10-13%.
Can go and buy Breville in a cylical industry with the same earnings growth on a 50% higher valuation multiple.
I'll sleep fine tonight.
Hey, don't knock Breville; it's quite the opposite of a cyclical business:![]()
In fact, its EPS over the past decade has grown at a CAGR of 8.5%pa; very similar to CSL.
Of course what is strikingly different is the respective P/E multiples of the two stocks which, while obviously totally different business models, demonstrate almost identical long-term growth:
CSL's prospective P/E multiple is around 25x; BRG's is 40x
I think some clear conclusions can be drawn from that wide spread.
(Actually, on second thoughts, maybe the two business models aren't so different, after all: both companies are R&D businesses, investing significant shareholder capital into developing unique and differentiated products which confer meaningful pricing power and hence, operating margins.)
.
- Forums
- ASX - By Stock
- CSL
- Ann: CSL Half Year Results Investor Presentation
CSL
csl limited
Add to My Watchlist
2.35%
!
$234.34

Ann: CSL Half Year Results Investor Presentation, page-95
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$234.34 |
Change
-5.640(2.35%) |
Mkt cap ! $113.4B |
Open | High | Low | Value | Volume |
$238.52 | $240.04 | $234.14 | $290.4M | 1.223M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 363 | $234.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$234.75 | 275 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 157 | 234.340 |
1 | 87 | 234.310 |
2 | 157 | 234.250 |
1 | 150 | 234.220 |
2 | 204 | 234.200 |
Price($) | Vol. | No. |
---|---|---|
234.750 | 275 | 1 |
235.450 | 194 | 1 |
235.500 | 1800 | 1 |
235.700 | 105 | 1 |
236.100 | 40 | 1 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online